Zhao, Y., Cheng, Q., Zou, S., Shi, X., Ouyang, M., & Sun, M. (2023). A Real-World Safety Analysis of Upadacitinib Based on FDA Adverse Event Reporting System (FAERS). Journal of Clinical Pharmacy & Therapeutics, 1. https://doi.org/10.1155/2023/8000874
Chicago Style (17th ed.) CitationZhao, Yazheng, Qian Cheng, Shupeng Zou, Xuan Shi, Mengling Ouyang, and Minghui Sun. "A Real-World Safety Analysis of Upadacitinib Based on FDA Adverse Event Reporting System (FAERS)." Journal of Clinical Pharmacy & Therapeutics 2023: 1. https://doi.org/10.1155/2023/8000874.
MLA (9th ed.) CitationZhao, Yazheng, et al. "A Real-World Safety Analysis of Upadacitinib Based on FDA Adverse Event Reporting System (FAERS)." Journal of Clinical Pharmacy & Therapeutics, 2023, p. 1, https://doi.org/10.1155/2023/8000874.